Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group von Campbell, Kevin, Gastier‐Foster, Julie M., Mann, Meegan, Naranjo, Arlene H., Ryn, Collin, Bagatell, Rochelle, Matthay, Katherine K., London, Wendy B., Irwin, Meredith S., Shimada, Hiroyuki, Granger, M. Meaghan, Hogarty, Michael D., Park, Julie R., DuBois, Steven G.

Volltext

Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group von Irwin, Meredith S, Naranjo, Arlene, Zhang, Fan F, Cohn, Susan L, London, Wendy B, Gastier-Foster, Julie M, Ramirez, Nilsa C, Pfau, Ruthann, Reshmi, Shalini, Wagner, Elizabeth, Nuchtern, Jed, Asgharzadeh, Shahab, Shimada, Hiroyuki, Maris, John M, Bagatell, Rochelle, Park, Julie R, Hogarty, Michael D

Volltext

Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial von Mody, Rajen, MD, Naranjo, Arlene, PhD, Van Ryn, Collin, MS, Yu, Alice L, Prof, London, Wendy B, PhD, Shulkin, Barry L, Prof, Parisi, Marguerite T, Prof, Servaes, Sabah-E-Noor, MD, Diccianni, Mitchell B, PhD, Sondel, Paul M, Prof, Bender, Julia G, MD, Maris, John M, Prof, Park, Julie R, Prof, Bagatell, Rochelle, Dr

Volltext

Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations von Brady, Samuel W., Liu, Yanling, Ma, Xiaotu, Gout, Alexander M., Hagiwara, Kohei, Zhou, Xin, Wang, Jian, Macias, Michael, Chen, Xiaolong, Easton, John, Mulder, Heather L., Rusch, Michael, Wang, Lu, Nakitandwe, Joy, Lei, Shaohua, Davis, Eric M., Naranjo, Arlene, Cheng, Cheng, Maris, John M., Downing, James R., Cheung, Nai-Kong V., Hogarty, Michael D., Dyer, Michael A., Zhang, Jinghui

Volltext

Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project von Sokol, Elizabeth, Desai, Ami V, Applebaum, Mark A, Valteau-Couanet, Dominique, Park, Julie R, Pearson, Andrew D J, Schleiermacher, Gudrun, Irwin, Meredith S, Hogarty, Michael, Naranjo, Arlene, Volchenboum, Samuel, Cohn, Susan L, London, Wendy B

Volltext

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project von Applebaum, Mark A, Vaksman, Zalman, Lee, Sang Mee, Hungate, Eric A, Henderson, Tara O, London, Wendy B, Pinto, Navin, Volchenboum, Samuel L, Park, Julie R, Naranjo, Arlene, Hero, Barbara, Pearson, Andrew D, Stranger, Barbara E, Cohn, Susan L, Diskin, Sharon J

Volltext

Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1 von Yanik, Gregory A, Parisi, Marguerite T, Naranjo, Arlene, Nadel, Helen, Gelfand, Michael J, Park, Julie R, Ladenstein, Ruth L, Poetschger, Ulrike, Boubaker, Ariane, Valteau-Couanet, Dominique, Lambert, Bieke, Castellani, Maria-Rita, Bar-Sever, Zvi, Oudoux, Aurore, Kaminska, Anna, Kreissman, Susan G, Shulkin, Barry L, Matthay, Katherine K

Volltext

Children's Oncology Group's 2013 blueprint for research: Renal tumors von Dome, Jeffrey S., Fernandez, Conrad V., Mullen, Elizabeth A., Kalapurakal, John A., Geller, James I., Huff, Vicki, Gratias, Eric J., Dix, David B., Ehrlich, Peter F., Khanna, Geetika, Malogolowkin, Marcio H., Anderson, James R., Naranjo, Arlene, Perlman, Elizabeth J.

Volltext

Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study von PARK, Julie R, SCOTT, Jeffrey R, STEWART, Clinton F, LONDON, Wendy B, NARANJO, Arlene, SANTANA, Victor M, SHAW, Peter J, COHN, Susan L, MATTHAY, Katherine K

Volltext

A subset of image‐defined risk factors predict completeness of resection in children with high‐risk neuroblastoma: An international multicenter study von Espinoza, Andres F., Bagatell, Rochelle, McHugh, Kieran, Naranjo, Arlene H., Van Ryn, Collin, Rojas, Yesenia, Lyons, Karen, Guillerman, R. Paul, Kirby, Chaim, Brock, Penelope, Volchenboum, Samuel, Simon, Thorsten, States, Lisa, Miller, Alexandra, Krug, Barbara, Sarnacki, Sabine, Irtan, Sabine, Brisse, Herve J., Valteau‐Couanet, Dominique, Schweinitz, Dietrich, Kammer, Birgit, Granata, Claudio, Pio, Luca, Park, Julie R., Nuchtern, Jed G.

Volltext

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology... von Ozkaynak, M Fevzi, Gilman, Andrew L, London, Wendy B, Naranjo, Arlene, Diccianni, Mitchell B, Tenney, Sheena C, Smith, Malcolm, Messer, Karen S, Seeger, Robert, Reynolds, C Patrick, Smith, L Mary, Shulkin, Barry L, Parisi, Marguerite, Maris, John M, Park, Julie R, Sondel, Paul M, Yu, Alice L

Volltext

Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma von Rosenberg, Miriam I., Greenstein, Erez, Buchkovich, Martin, Peres, Ayelet, Santoni-Rugiu, Eric, Yang, Lei, Mikl, Martin, Vaksman, Zalman, Gibbs, David L., Reshef, Dan, Salovin, Amy, Irwin, Meredith S., Naranjo, Arlene, Ulitsky, Igor, de Alarcon, Pedro A., Matthay, Katherine K., Weigman, Victor, Yaari, Gur, Panzer, Jessica A., Friedman, Nir, Maris, John M.

Volltext

Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group von Wang, Larry L., Suganuma, Rie, Ikegaki, Naohiko, Tang, Xao, Naranjo, Arlene, McGrady, Patrick, London, Wendy B., Hogarty, Michael D., Gastier‐Foster, Julie M., Look, A. Thomas, Park, Julie R., Maris, John M., Cohn, Susan L., Seeger, Robert C., Shimada, Hiroyuki

Volltext

CASZ1b, the short isoform of CASZ1 gene, coexpresses with CASZ1a during neurogenesis and suppresses neuroblastoma cell growth von Liu, Zhihui, Naranjo, Arlene, Thiele, Carol J

Volltext

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study von Vermeulen, Joëlle, MD, De Preter, Katleen, PhD, Naranjo, Arlene, PhD, Vercruysse, Liesbeth, BSc, Van Roy, Nadine, Prof, Hellemans, Jan, PhD, Swerts, Katrien, PhD, Bravo, Sophie, MD, Scaruffi, Paola, PhD, Tonini, Gian Paolo, PhD, De Bernardi, Bruno, MD, Noguera, Rosa, Prof, Piqueras, Marta, PhD, Cañete, Adela, MD, Castel, Victoria, MD, Janoueix-Lerosey, Isabelle, PhD, Delattre, Olivier, MD, Schleiermacher, Gudrun, MD, Michon, Jean, MD, Combaret, Valérie, PhD, Fischer, Matthias, MD, Oberthuer, André, MD, Ambros, Peter F, PhD, Beiske, Klaus, PhD, Bénard, Jean, PhD, Marques, Bárbara, MSc, Rubie, Hervé, MD, Kohler, Janice, MD, Pötschger, Ulrike, MSc, Ladenstein, Ruth, MD, Hogarty, Michael D, MD, McGrady, Patrick, MSc, London, Wendy B, PhD, Laureys, Geneviève, Prof, Speleman, Frank, Prof, Vandesompele, Jo, Prof

Volltext

Response to induction chemotherapy modifies the effect of conventional prognostic factors in high-risk neuroblastoma: A report from the Children’s Oncology Group von Sokol, Elizabeth, LaBarre, Brian, Pinto, Navin, Kreissman, Susan, Granger, M. Meaghan, Park, Julie R., Bagatell, Rochelle, Naranjo, Arlene, DuBois, Steven G.

Volltext

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a repo... von Niemas-Teshiba, Risa, Matsuno, Ryosuke, Wang, Larry L, Tang, Xao X, Chiu, Bill, Zeki, Jasmine, Coburn, Jeannine, Ornell, Kimberly, Naranjo, Arlene, Van Ryn, Collin, London, Wendy B, Hogarty, Michael D, Gastier-Foster, Julie M, Look, A Thomas, Park, Julie R, Maris, John M, Cohn, Susan L, Seeger, Robert C, Asgharzadeh, Shahab, Ikegaki, Naohiko, Shimada, Hiroyuki

Volltext

Primary nephrectomy and intraoperative tumor spill: Report from the Children's Oncology Group (COG) renal tumors committee von Gow, Kenneth W, Barnhart, Douglas C, Hamilton, Thomas E, Kandel, Jessica J, Chen, Mike K.S, Ferrer, Fernando A, Price, Mitchell R, Mullen, Elizabeth A, Geller, James I, Gratias, Eric J, Rosen, Nancy, Khanna, Geetika, Naranjo, Arlene, Ritchey, Michael L, Grundy, Paul E, Dome, Jeffrey S, Ehrlich, Peter F

Volltext

Persistence of racial and ethnic disparities in risk and survival for patients with neuroblastoma over two decades von Chennakesavalu, Mohansrinivas, Pudela, Caileigh, Applebaum, Mark A., Lee, Sang Mee, Che, Yan, Naranjo, Arlene, Park, Julie R., Volchenboum, Samuel L., Henderson, Tara O., Cohn, Susan L., Desai, Ami V.

Volltext

KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children’s Oncology Group von Erbe, Amy K, Diccianni, Mitch B, Mody, Rajen, Naranjo, Arlene, Zhang, Fan F, Birstler, Jen, Kim, KyungMann, Feils, Arika S, Hung, Jung-Tung, London, Wendy B, Shulkin, Barry L, Mathew, Varsha, Parisi, Marguerite T, Servaes, Sabah, Asgharzadeh, Shahab, Maris, John M, Park, Julie, Yu, Alice L, Sondel, Paul M, Bagatell, Rochelle

Volltext